These physiological perturbations can interact with cardiovascular phenotypes and prothrombotic states to play a significant role in stroke recurrence, functional outcome (Arboix, 2015), and outcome with pharmacological intervention with tissue plasminogen activator (tPA) (Seet et al., 2014). The gene discussed is PLAT; the disease is Stroke.